During the past decade, Organización Médica de Investigación conducted 38 clinical trials. In the 10-year time frame, 38 clinical trials started and 28 clinical trials were completed, i.e. on average, 73.7% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 21 clinical trials were completed. i.e. 116.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Organización Médica de Investigación" #1 sponsor was "Hoffmann-La Roche" with 22 trials, followed by "Pfizer" with 5 trials sponsored, "Bristol-Myers Squibb" with 3 trials sponsored, "Genentech, Inc." with 3 trials sponsored and "R-Pharm International, LLC" with 3 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Organización Médica de Investigación" #1 collaborator was "Chugai Pharmaceutical" with 3 trials as a collaborator, "OCT Clinical Trials" with 3 trials as a collaborator, "Quintiles, Inc." with 2 trials as a collaborator, "IQVIA Pvt. Ltd" with 1 trials as a collaborator and "Mene Research" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Organización Médica de Investigación" are "Rheumatoid Arthritis" (11 trials), "Diabetic Macular Edema" (4 trials), "Geographic Atrophy" (4 trials), "Lupus Nephritis" (4 trials) and "Arthritis, Rheumatoid" (3 trials). Many other conditions were trialed in "Organización Médica de Investigación" in a lesser frequency.

Most popular intervention types in "Organización Médica de Investigación" are "Drug" (44 trials), "Other" (14 trials), "Biological" (4 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Sham Procedure" (10 trials), "Faricimab" (6 trials), "Aflibercept" (4 trials) and "Methylprednisolone" (4 trials). Other intervention names were less common.

The vast majority of trials in "Organización Médica de Investigación" are 47 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Organización Médica de Investigación". undefined are not yet recruiting, 8 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Organización Médica de Investigación, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Organización Médica de Investigación, 0 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 29 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".